2/ The U.S.–Ukraine “biolab” record starts with BTRP:
DTRA says the program partnered with Ukraine from 2005 to improve peaceful biological detection/diagnostic capacity and reduce risks from dangerous pathogens. (1) gusquixote.com/article/part-t…
May 6 • 14 tweets • 6 min read
🧵Hantavirus an Anthony Fauci Gain-of-Function Frankenstein gone wrong?
Public records show U.S.–China overlap in hantavirus clinical treatment research, surveillance, molecular epidemiology, phylogenetics, reservoir-host research, and natural reassortment/pathogenicity studies.
2/ Hantavirus U.S.–China overlap isn’t one visible “joint GOF program.”
Public record points to cooperation in treatment trials, surveillance, molecular epidemiology, host-jump ecology, reassortment analysis, and countermeasures. (1)
May 6 • 14 tweets • 5 min read
1/ Hantavirus spillover research in China with U.S.-affiliated scientists clusters into 3 lanes:
Chinese human HFRS surveillance.
Chinese rodent/isolate genetics.
Ecological risk modeling.
“American scientists” here means U.S. institutional affiliation at publication, not confirmed nationality. (1)2/ One early U.S.-China trail runs through USAMRIID.
In 1993, S.Y. Xiao and C.S. Schmaljohn characterized HV114, a hantavirus isolated from an HFRS patient in Hubei, China, using antigenic comparison and M-segment sequencing. (1)
2/ The U.S.–Ukraine “biolab” record starts with BTRP:
